CareCredit integration with Intelibly puts Synchrony Financial in focus
Synchrony Financial (SYF) moved into the spotlight after Intelibly Inc. said it will embed the CareCredit health and wellness card into its dental platform, bringing patient financing directly into the appointment booking process.
Synchrony Financial has pulled back recently, with the share price down 5.1% over the past week and 6.3% over the last month, even as the 1 year total shareholder return is slightly positive and the 3 year total shareholder return is very large. This suggests longer term investors have still seen strong gains, while short term sentiment has cooled despite news like the Intelibly and CareCredit integration and the upcoming Barclays conference appearance.
Capitalize on Synchrony Financial’s CareCredit momentum by scanning a hand-picked 35 high quality undervalued stocks that pair solid balance sheets with patient financing or consumer credit exposure.Synchrony Financial has a long record in consumer credit and fresh momentum from CareCredit partnerships, yet the share price has cooled in recent weeks. So is that recent pullback offering fair value or false comfort?
Most Popular Narrative: 15% Undervalued
Synchrony Financial last closed at $75.88, while the most followed narrative anchors fair value around $89.22, implying a sizeable valuation gap that rests on how well the business can hold credit quality and keep returning capital to shareholders.
The company's proactive investment in advanced data analytics, AI, and end-to-end digital platforms, including deeper digital integration of new cards with PayPal and Walmart, enhances risk management and operational efficiency, thereby supporting improved net interest margins and lower charge-offs as these technologies mature.
See why 35 investors see Synchrony Financial as 15% undervalued.
The fair value narrative is built on a discount rate of 9.12%, forecast revenue growth of 18.93% and an earnings profile that nudges the future P/E multiple to 10.35x. That framework implies investors are paying for a consumer finance business with $9.9b in revenue today, $3.4b in net income and a 20.8% return on equity, but also accepting that earnings are expected to decline by about 2.3% per year over the next three years as credit costs and competition bite.
Analysts expect profit margins to settle closer to 18.2% over time rather than the mid 30% area, while still assuming the share count shrinks by about 7% a year, which can lift earnings per share even if total profit softens. That mix of shrinking net income, solid capital returns and embedded finance partnerships helps explain why the narrative still lands on a fair value near $89.22 despite cautious earnings forecasts.
For readers weighing whether the recent pullback in Synchrony Financial reflects opportunity or rising risk, the key question is simple. Do those long term assumptions about revenue growth, margin compression and buybacks feel realistic for a lender with high quality earnings but a relatively high level of bad loans at 2%?
Result: Fair Value of $89.22 (UNDERVALUED)
Still, the narrative around Synchrony Financial can crack if major retail partners pull back, or if regulatory changes squeeze fees and credit profitability faster than models assume.
Find out about the key risks to this Synchrony Financial narrative.
Next Steps
Sentiment around Synchrony Financial is mixed, with clear upside arguments sitting right beside real concerns about credit risk and partner exposure. Act quickly and test those assumptions against the underlying data by weighing up the 3 key rewards and 2 important warning signs.
Looking for more investment ideas beyond Synchrony Financial?
Do not stop with Synchrony Financial. Broaden your watchlist now so you are not relying on a single lender when fresh opportunities start to line up.
- Explore potential upside in quality plays that trade below estimated worth by scanning a curated pool of 35 high quality undervalued stocks.
- Build a cash flow focused portfolio by zeroing in on companies that pay at least 5% and feature resilient payouts through the 6 dividend fortresses.
- Surface lesser known opportunities with strong fundamentals before they become crowded trades by running the 15 high quality undiscovered gems.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com